Citigroup Issues Pessimistic Forecast for Mirion Technologies (NYSE:MIR) Stock Price

Mirion Technologies (NYSE:MIR) had its target price reduced by research analysts at Citigroup from $29.00 to $28.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Citigroup’s price objective suggests a potential upside of 42.65% from the company’s current price.

Several other equities research analysts have also recently commented on the company. Melius Research raised Mirion Technologies to a “strong-buy” rating in a research note on Monday, March 23rd. The Goldman Sachs Group cut their price objective on shares of Mirion Technologies from $33.00 to $29.00 and set a “buy” rating on the stock in a research report on Thursday, February 12th. Morgan Stanley decreased their target price on shares of Mirion Technologies from $29.00 to $27.00 and set an “equal weight” rating for the company in a research report on Wednesday, March 11th. JPMorgan Chase & Co. dropped their price target on shares of Mirion Technologies from $30.00 to $27.00 and set an “overweight” rating on the stock in a research note on Thursday, March 26th. Finally, Robert W. Baird cut their price target on shares of Mirion Technologies from $29.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, March 30th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $27.13.

Mirion Technologies Trading Down 0.6%

NYSE MIR opened at $19.63 on Thursday. The company has a current ratio of 3.19, a quick ratio of 2.34 and a debt-to-equity ratio of 0.63. Mirion Technologies has a 1-year low of $15.55 and a 1-year high of $30.28. The firm’s fifty day simple moving average is $19.78 and its 200-day simple moving average is $23.17. The company has a market capitalization of $4.92 billion, a PE ratio of 196.28 and a beta of 1.07.

Mirion Technologies (NYSE:MIR) last released its quarterly earnings data on Tuesday, April 28th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.09 by $0.01. Mirion Technologies had a return on equity of 6.44% and a net margin of 2.56%.The firm had revenue of $257.60 million during the quarter, compared to analysts’ expectations of $244.78 million. During the same quarter last year, the firm earned $0.10 earnings per share. The business’s revenue for the quarter was up 27.5% on a year-over-year basis. Mirion Technologies has set its FY 2026 guidance at 0.480-0.550 EPS. As a group, sell-side analysts anticipate that Mirion Technologies will post 0.51 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. Advisory Services Network LLC bought a new stake in Mirion Technologies during the third quarter valued at about $25,000. Wolff Wiese Magana LLC acquired a new position in shares of Mirion Technologies during the 3rd quarter worth about $26,000. Salomon & Ludwin LLC acquired a new position in shares of Mirion Technologies during the 3rd quarter worth about $30,000. UMB Bank n.a. boosted its stake in Mirion Technologies by 175.4% during the 4th quarter. UMB Bank n.a. now owns 1,344 shares of the company’s stock valued at $31,000 after purchasing an additional 856 shares during the period. Finally, EverSource Wealth Advisors LLC boosted its stake in Mirion Technologies by 470.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,642 shares of the company’s stock valued at $35,000 after purchasing an additional 1,354 shares during the period. Institutional investors own 78.51% of the company’s stock.

About Mirion Technologies

Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.

Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.